Announcements Trials

Browse Landscape

Phase

Phase NA 6 Phase 2 5 Phase 4 2 Phase 3 1 Phase 1/2 1

Status

Completed 5 Recruiting 2 Unknown 1 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 143 Colorectal Neoplasms 97 Carcinoma, Non-Small-Cell Lung 97 Carcinoma, Hepatocellular 69 Stomach Neoplasms 65 Rectal Neoplasms 54 Neoplasms 53 Lung Neoplasms 45 Colonic Neoplasms 41 Nasopharyngeal Carcinoma 39 Leukemia, Myeloid, Acute 39 Prostatic Neoplasms 38 Lymphoma, Large B-Cell, Diffuse 38 Uterine Cervical Neoplasms 36 Neoplasm Metastasis 33 Ovarian Neoplasms 32 Esophageal Neoplasms 32 Multiple Myeloma 31 Lymphoma 31 Lymphoma, Follicular 30 Leukemia 28 Pancreatic Neoplasms 27 Recurrence 22 Head and Neck Neoplasms 22 Brain Neoplasms 21 Urinary Bladder Neoplasms 19 Precursor Cell Lymphoblastic Leukemia-Lymphoma 19 Lymphoma, Non-Hodgkin 19 Squamous Cell Carcinoma of Head and Neck 17 Lymphoma, Mantle-Cell 17

Interventions

Temozolomide 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Unknown × Disease Progression × Clear all

NCT02761070 2023-03-08

RE-GEND

Kyorin University

Phase 3 Unknown

Glioblastoma, Recurrence, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡